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In responding to the widespread impacts of the COVID-19 pandemic, countries
have proposed and implemented documentation policies that confer varying
levels of freedoms or restrictions (e.g., ability to travel) based on individuals’
infection status or potential immunity. Most discussions around immunity- or
infection-based documentation policies have focused on scientific plausibility,
economic benefit, and challenges relating to ethics and equity. As COVID-19
vaccines are rolled out, attention has turned to confirmation of immunity and
how documentation such as vaccine certificates or immunity passports can be
implemented. However, the contextual inequities and local variabilities inter-
acting with COVID-19 related documentation policies hinder a one-size-fits-all
approach. In this Comment, we argue that social science perspectives can and
should provide additional insight into these issues, through a diverse range of
current and historical examples. This would enable policymakers and
researchers to better understand and mitigate current and longer-term differ-
ential impacts of COVID-19 immunity-based documentation policies in different
contexts. Furthermore, social science research methods can uniquely provide
feedback to inform adjustments to policy implementation in real-time and help
to document how these policy measures are felt differently across communities,
populations, and countries, potentially for years to come. This Comment,
updated as of 15 August 2021, combines precedents established in historical
disease outbreaks and current experiences with COVID-19 immunity-based
documentation policies to highlight valuable lessons and an acute need for
further social science research which should inform effective and context-
appropriate future public health policy and action.
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COVID-19 related documentation such as passports, certi-ficates, and licences have been subject to increasing dis-cussion throughout the pandemic (Organization, 2020b).
In various contexts, this documentation implies different rights,
restrictions, and/or freedoms, based on presumed immunity- or
infection-based criteria. Furthermore, these policies have impli-
cations at both the domestic and international levels (The Lancet
Microbe, 2021). For example, COVID-19 policies implemented
early in Denmark and India (and now used by many countries)
focus on proving freedom from current infection (Drury, 2020;
2020b), and in El Salvador and Brazil certify an individual’s
recovery from infection (Phillips, 2020; 2020a). Initially this was
to prevent transmission from areas of high burden to those with
lower burden of infection; however recently the focus has swit-
ched to preventing introduction of new variants of the SARS-
CoV-2 (Callaway, 2021). As COVID-19 vaccines were rolled out,
attention turned to confirmation of immunity. Many of the same
questions and concerns are being raised, and the term ‘immunity
passport’ is being applied to potential policies based on vacci-
nation status documentation, such as the European Union’s
Digital COVID Certificate rolling out in July 2021 (Picard, 2020;
2021c; Gostin et al., 2021). There is therefore a continued need to
consider the debates over the last year around ‘immunity pass-
ports’ in the context of vaccination, and what these discussions
reveal about the kinds of research and voices needed to better
inform policy actions.
Immunity-based documentation is not a new practice in global
health governance; today its most recognisable implementation is
the yellow fever vaccination certificates required for travel to or
from various countries (World Health Organization, 2015). To
date, most discussions around immunity-based documentation
for COVID-19 have focused on scientific soundness, economic
benefit, and ethical challenges of implementation whilst drawing
on a narrow selection of historical examples (Persad and
Emanuel, 2020; Voo et al., 2020; Phelan, 2020; Voo et al., 2021).
Although important contributions, these perspectives miss the
real human lives, day-to-day experiences, and ‘messy middle-
grounds’ that underpin them. Here, we argue that discussions
around COVID-19 immunity-based documentation should
include greater input from humanities and social sciences such as
sociology, anthropology, and history to better understand the
immediate, short- and long-term impacts of such policies.
Through using diverse current and historical examples, we sug-
gest increased attention to the role of context in particular.
Greater social science input into health policy decision-making in
pandemic preparedness and response adds further richness to
understandings of these issues, and the lives and realities with
which they are intertwined, and is essential to inform effective
health policies and implementation. To this end, we need social
science research investigating the impact and experience of
immunity-based documentation policies when and where they
unfold.
What is immunity, how is it being measured, and what does it
mean?
The approaches being considered for confirming immunity to
SARS-CoV-2 focus on different aspects of infection, immunity,
and transmission. Options vary regarding what they indicate
about the virus and immune response, and therefore have dif-
ferent implications when resulting in a positive or negative test.
Table 1 summarises the biomedical and epidemiological rationale
and pitfalls of these approaches, refers to parallels from other
infectious diseases, and raises potential accessibility and equity
implications, which have been the focus of recent debate
regarding vaccination. The International Health Regulations,
which are drawn up through international consensus for infec-
tions such as yellow fever, do not yet govern travel based on
vaccination for COVID-19, thus resulting in heterogeneity of
approaches between countries (Ferhani and Rushton, 2020;
World Health Organization, 2021). For example, there are con-
cerns about lack of coordination and transparency of restrictions
to inter-country travel.
The World Health Organization’s Director-General has
warned world leaders of significant inequity of access to vaccines
(World Health Organization, 2021), asking that the COVAX
initiative, set up to improve global access to COVID-19 vaccines,
not be undermined (Public Health England, 2020). This inequity
in vaccine distribution and its implications for vaccination cov-
erage in low and middle-income countries, is further manifested
by current COVID-related documentation policies that limit
which vaccinations will be accepted by the schemes (Borana,
2021). For example, while India’s Serum Institute manufactures
the Oxford-AstraZeneca vaccine under a different name, Cov-
ishield, it is currently not approved by the European Medicines
Agency and therefore not accepted in the EU digital COVID
certificate scheme (Borana, 2021). A number of additional
COVID-19 vaccines have been produced (for example, in Russia
and in China) and more are vying for WHO approval status for
emergency use.
The implementation of immunity-based documentation to
grant various freedoms to individuals also raises questions about
the implications this has for assumed mandatory vaccination and
if and how exemptions will be considered. Further, given
uncertainty regarding the length of immunity conferred by
infection and/or vaccination, protocols for re-issuing immunity-
based documentation for the same individual must also be con-
sidered. Bringing conversations around vaccination and
immunity-based documentation together, the final column in
Table 1 suggests related potential priority areas that social science
research could help to address, drawing on a crowd-sourced
document of medical anthropological research questions (Nichter
et al., 2020).
Historical precedents
As variants of COVID-19 emerge, past experience with other
infectious diseases has been one important source of information
to guide current action. As multiple commentators highlight,
immunity-based documentation policies that allow freedoms to
certain populations while restricting others’ may result in people
seeking infection in order to access these freedoms as well
(Phelan, 2020). Such commentaries have frequently pointed to
two cautionary historical precedents of intentional infection:
yellow fever in the US antebellum South and ‘chicken pox parties’
in the twentieth century. It is important to consider that whilst
intentional infection may be encouraged by policies and doc-
umentation requiring proof of infection (e.g., ‘immunity’ pass-
ports), policies and documentation requiring proof of vaccination
rather incentivise seeking vaccination (e.g., ‘vaccine’ passports)
(Osama et al., 2021). However, the pursuit of intentional infection
may remain a risk in the COVID-19 pandemic where access to
vaccines is lacking. While seeking ‘natural immunity’ may be
prioritised as a lifestyle choice in the global north, it may be the
only option in many countries around the world with limited
vaccine availability. Policymakers must consider how to safeguard
against these activities while also balancing the pressure to con-
struct a coherent ‘success story’ that may skew the apparent cost
and benefit of an immunity-based documentation policy (Das,
1999).
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However, other precedents and models should also inform our
approaches to COVID-19, especially as we consider the range of
policies being used or proposed. For instance, a recent negative
swab PCR test prior to travel is either required for individuals to
enter or may remove/reduce the duration of quarantine on arrival
in many countries; however, this practice does not govern the
process for acquiring that test, which might be prone to differ-
ential ease of access (Drury, 2020; 2020b). Drawing from previous
examples in history, a system of physician-certified immunity was
implemented in Gibraltar in 1828 for yellow fever, possibly the
earliest surviving example of such passes (Sawchuk and Tripp,
2021). Almost a century later, the use of health certificates was
adopted by various city health departments and the state of New
York during the 1916 polio epidemic in the Northeastern United
States. However, a health certificate from a private physician was
not enough to certify a child ‘free of infection,’ on the basis that
they could not be trusted to put the good of the community ahead
of their patients’ convenience (Rogers, 1986). Even with an offi-
cial health certificate in hand, New York children were therefore
frequently refused entry to nearby towns or threatened with
quarantines as long as four weeks (Rogers, 1986). In the current
case, variations in COVID-19 restriction policies and testing
requirements for travel have led to private providers meeting the
demands for PCR tests, raising potential issues around equity and
access to testing. This profiteering extends to recent reports of
selling fraudulent COVID-19 test results, which has led to sug-
gestions that traditional paper-based certification is not trust-
worthy (Ellyatt, 2021; Werthmuller, 2021).
As another example of the pitfalls of such testing, mandatory
intermittent testing of sex workers for HIV and other sexually
transmitted infections has been argued to be an ineffective use of
funds and to confer a false sense of security, in part due to the
‘window periods’ during which infections may go undetected
(Jeffreys et al., 2012). Similar concerns have been raised in regards
to SARS-Cov-2 PCR tests; COVID-19 has an average incubation
(‘window’) period of around five days after exposure to the virus,
during which PCR tests are usually negative (Böger et al., 2021).
Furthermore, there is potential danger for the certificate itself to
become the focus and goal of these clinical interactions, rather
than the health of the individual or wider community (Jeffreys
et al., 2012). This potentially increases the likelihood of fraud and
may impact the ability to access testing for symptomatic indivi-
duals, due to unclear priorities for resource allocation (Jeffreys
et al., 2012). For COVID-19, it may matter who does the testing
and issues documentation, and if they are seen as impartial,
reliable, and trustworthy. Further, profitable pre-travel testing in
some contexts may lead to the diversion of private laboratory
resources potentially away from local health priorities.
With various vaccines in the pipeline, and vaccination pro-
grammes already beginning in many countries, we must again
learn from history to ensure equitable access to the immunity
they provide and the associated documentation. During the
1913 smallpox epidemic in New Zealand, successful vaccination
enabled Māori to obtain a certificate for exemption from travel
restrictions. However, travel to a town or city for the vaccine itself
was possible only with documentation of previous vaccination,
which many Māori did not have, creating a catch-22 that further
entrenched existing disparities (Day, 1998). Despite Māori being
most at risk in this epidemic, they had the most difficulty
obtaining vaccines, as European New Zealanders prioritised their
own protection (Day, 1998). With COVID-19, establishing
equitable allocation and access to approved vaccines is a chal-
lenge. The COVAX initiative relies on global solidarity to finance
and distribute the needed vaccines (Herzog et al., 2021). However
equitable access to COVID-19 vaccines for global populations
requires not only fair allocation of the vaccine but also systems in
place to produce and deploy affordable vaccines at scale as well as
mechanisms to promote vaccine acceptance (Herzog et al., 2021;
Wouters et al., 2021).
Immunity-mediated certification has been used historically,
and will likely be used again in future epidemic or crises settings.
In the development and implementation of national and inter-
national COVID-19 related documentation measures, we must
consider diverse historical precedents for immunity-based privi-
leges, current scientific knowledge around COVID-19 immunity
and testing, and the local context and implications of these
policies. COVID-19 related documentation is a space char-
acterised by significant uncertainty. While immunity from pre-
vious infection and potential for transmission after inoculation
with a vaccine remain unclear (Peiris and Leung, 2020), a focus
on the presence or absence of the virus itself is a narrow way to
define health and wellbeing. Further, human biology cannot be
assumed to look and work the same way across populations,
space, and time. Researchers, advisors, and policymakers must
learn from diverse cases in order to produce health policies that
can work for different people on the ground.
The importance of context
When considering contextual factors that shape and are shaped
by COVID-19 related documentation in practice, social science
perspectives, methods, and theory are particularly valuable. Calls
for increased engagement with social science methods and theory
in implementation science emphasise that: ‘It is not enough to
know if a health intervention is effective; it is also necessary to
understand why the intervention works, how, for whom and in
which contexts’ (Ridde, 2016). In terms of COVID-19, the
reception of introducing and implementing documentation
policies is influenced by the societal norms and expectations in
the local context. For example, Israel, a country with compulsory
national identity card regulations was one of the first nations to
introduce the Green Pass (2021i). Meanwhile, such documenta-
tion policies have been largely criticised by lawmakers and the
public in Ireland, the United Kingdom, and the United States—
nations without compulsory identity cards (Allegretti, 2021).
Furthermore, a recent study analysing religious opposition to
vaccination in the UK and Israel highlights how politicising
discourses of ‘beliefs’ and ‘hesitancy’ frame religion and culture as
obstacles to the intervention, whilst often obscuring and delegi-
timising the situated, structural, and wider contextual issues that
crucially inform individuals’ decisions and concerns about bio-
medical technology, its production, and how it is governed
(Kasstan, 2021).
There are many different social science models and under-
standings of context, yet a key part of many of these is an
appreciation of complexity and interaction of dynamic multi-level
processes (Greenhalgh et al., 2017; May and Finch, 2009). Social
science literature on implementation, discussing how health
policies and guidelines unfold and are done in practice, highlights
that this is not a straightforward undertaking that happens the
same way everywhere for everyone (Greenhalgh et al., 2017; May
and Finch, 2009; Ridde, 2016; Van Belle et al., 2017). However,
more positivist accounts discuss ‘following’ or ‘adhering’ to health
policies or guidelines, implying a linear process echoing the logic
of determinism (Durlak and Dupre, 2008; Fischer et al., 2016).
These accounts frame contextual realities through the lens of
‘barriers’ and ‘facilitators’ to effective implementation—rather
than incorporating these considerations into policy and guideline
development to better accommodate and reflect them.
Ethical and biomedical lenses have dominated discussions of
COVID-19 related documentation, focusing on universal princi-
ples that should guide implementation (or not) (Brown et al.,
COMMENT HUMANITIES AND SOCIAL SCIENCES COMMUNICATIONS | https://doi.org/10.1057/s41599-021-00898-4
6 HUMANITIES AND SOCIAL SCIENCES COMMUNICATIONS |           (2021) 8:219 | https://doi.org/10.1057/s41599-021-00898-4
2020; Kofler and Baylis, 2020; Voo et al., 2020). Here, some of the
social determinants of health are considered in questions of
equity, stigma, and access. While these perspectives are essential,
they are incomplete. They should also be complemented by fur-
ther social science research into local realities and experiences
that reveal how such policies become situated in lived context for
individuals and whole groups, as illustrated by the historical
examples above. A recent rapid review of public attitudes and
behavioural responses towards COVID-status certification found
that their conclusions about people’s underlying reasoning were
limited by the quality and quantity of the published studies, with
high income countries overrepresented and most studies lacking
demographic measures (Drury et al., 2021). The authors also note
that these attitudes are likely to change over time, so studies
conducted in 2020 based on hypothetical scenarios are likely to
differ in their findings from those conducted now (Drury et al.,
2021). We need this information to better understand and con-
textualise potential benefits and harm, and support necessary
local adaptations.
The translation of science into policy and practice is similarly
not a-contextual, as ‘evidence does not form guidelines on its
own’ (Atkins et al., 2013). From the makeup and interactions of
committee members, to the interaction of different policymaking
sectors, to how evidence is considered, biomedical or scientific
evidence should not be the only kind of evidence upon which
these policies are based. We know that the ‘success of [public
health] interventions depends on local feasibility, acceptability,
and fit with context—and hence on informed, shared decision-
making with and by local communities’ (Greenhalgh et al., 2014).
Equally, a diversity of voices should feature in policy development
processes, as well as in the implementation and communication
of new policies, representing a diversity of experiences, interests,
and priorities.
Bringing these local priorities and perceptions to the table is
imperative. While economic and social considerations have fea-
tured in COVID-19 related documentation discussions over the
last year (World Health Organization, 2020b; Das, 1999; Phelan,
2020; 2020c), one of the less explored questions is how the intense
focus on COVID-19 is perceived and experienced in different
settings. These differences in priorities affect the implementation
of any policy or health intervention (Yarborough et al., 2013).
The polio eradication programme in Nigeria, for example, high-
lights the frustration of local people who saw public health
priorities not reflecting their own (but those of wealthier others),
as resources were directed to polio over basic healthcare and
other diseases that impacted them more (Maryam, 2007).
Moving forward
Immunity-based documentation is already being implemented in
various countries to various extents, with Israel’s Green Pass
regulating entry to public spaces, Air New Zealand’s trial of the
Travel Pass mobile app which stores health information such as
COVID-19 test results and vaccination status in March 2021, and
the more recent rollout of the EU Digital Certificate in July 2021
(Holmes and Kierszenbaum, 2021; 2021a; 2021c). These policies
have been incorporated to various extents in different countries—
from regulating domestic or international travel to restricting
entry to large events and public spaces. The public reception to
these policies has been mixed—leading to increased vaccination
rates in Italy and France as well as protests in France and Canada
(Hart, 2021; Jonas, 2021). While it is too early to comprehensively
understand the implications of these policies, collecting data on
these experiences is helpful in not only providing feedback to
adjust policies and their implementation, but to also mitigate any
harms that may arise in relative real-time. The effects of these
measures and challenges with varying implementation will be felt
differently across communities, populations, and countries
potentially for years to come. These measures will become pre-
cedents for future policies, and will form the infrastructure for
further public and global health systems. The perceived success of
such measures will be determined by who you ask, when you ask
them, and where they are. As such, these measures should not be
uncritically transplanted from one context to another.
In prioritising a ‘return to normalcy,’ various countries have
introduced policies for immunity passports that raise concerns
about inequity by favouring more privileged populations. For
example, when COVID-19 restrictions in Canada were
announced at the end of 2020, the Immigration Minister
exempted over 1700 athletes and business travellers from quar-
antine requirements (Harris, 2020). What does all of this reveal
about the politics of life, and which lives—and which livelihoods—
are valued? Studying these phenomena can add meaningfully to
social science theory, which can and should feed back into the
development of these policies, in order—rather than to ‘return to
normal’—to challenge the status quo and attending inequities, and
better inform short- and longer-term public health responses. The
experience gleaned from both diverse historical precedents and
current social science research on the ongoing regulations to limit
disease spread can broaden understandings of longer-term
impacts and inform future effective and context-appropriate
health policy and action.
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